📢 News: Sonrai Accelerates Cancer Therapeutics Research with Advanced Analytics 📰 Read now: https://lnkd.in/dPMqy8D2 Sonrai’s AI data management and analysis technology will enable the Henri & Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital to manage vast multi-omic and multi-modal data to accelerate oncological research into personalized therapies using advanced analytics. 👋 To discuss how we can help advance your therapeutics development, book a chat with us: https://lnkd.in/dEnkdQdV #precisionmedicine #oncology #AI #dataanalytics #Sonrai #SonraiDiscovery #drugdevelopment #immunooncology #biomarkerdiscovery
Sonrai’s Post
More Relevant Posts
-
An important new white paper, released today, highlights Predictive Oncology’s success in using artificial intelligence-powered evidence-based molecular decision-making for improved outcomes in ovarian cancer. This white paper details a multi-year collaboration between Predictive Oncology and UPMC Magee-Womens Hospital applying data-driven artificial intelligence machine learning (ML) to predict survival outcomes for ovarian high grade serous carcinoma patients (HGSC). Visit https://lnkd.in/gwzK8xZJ to download the study. #drugdiscovery #drugdevelopment #pharma #emergingtechnologies #biopharma #biomarker #biomarkerdiscovery #molecularbiology #oncologydrugdiscovery #oncology #machinelearning #AI #marketaccess #artificialintelligence #digitaltransformation #cancerresearch #biotech #lifesciences #POAI
To view or add a comment, sign in
-
🔈 📣 interested to learn about strategies for optimizing ADCs, overcoming resistance, and combining them with immuno-oncology therapies? 👉 Check out this webinar below! #ADC #cancertreatment #crownbioscience 🔬
🔬 Join Crown Bioscience for an upcoming webinar to explore how Antibody-drug conjugates (ADCs) are revolutionizing cancer treatment with improved targeting, reduced toxicity, and enhanced efficacy. 💡 Learn about cutting-edge advancements in bioconjugation technology and multi-omics approaches driving ADCs from preclinical to clinical stages. 🔍 Dr. Peng Wang, PhD, will share strategies for optimizing ADCs, overcoming resistance, and combining them with immuno-oncology therapies. ➡️ REGISTER HERE: https://buff.ly/3A9LOzt #DrugDevelopment #PrecisionMedicine #DrugDiscovery #ClinicalResearch #Oncology #OncologyDrugs #TherapeuticAreas #AntibodyDrugConjugate #PreClinical #BasicResearch
To view or add a comment, sign in
-
New Blog💡 Climbing the Mountain: Current Challenges in Early Phase Oncology Clinical Trials https://lnkd.in/gxZUjyfZ In this blog we explore the pivotal role of Phase I and II clinical trials in oncology research, a fundamental step towards innovative cancer treatments. Despite their importance, these trials encounter significant obstacles: Key Takeaways: ~ Recruitment: Overcoming stringent criteria and patient concerns is key. Utilizing broad CRO networks and strategic patient identification can help. ~Biomarker Identification: Essential for precision medicine, yet complex due to tumor biology. Requires sophisticated assays for effective treatment targeting. ~Regulatory Navigation: Streamlining the process through expert collaboration and specialized CROs is vital to expedite therapy advancement. #OncologyTrials #ClinicalResearch #RegulatoryScience #TD2
To view or add a comment, sign in
-
🔬 Join Crown Bioscience for an upcoming webinar to explore how Antibody-drug conjugates (ADCs) are revolutionizing cancer treatment with improved targeting, reduced toxicity, and enhanced efficacy. 💡 Learn about cutting-edge advancements in bioconjugation technology and multi-omics approaches driving ADCs from preclinical to clinical stages. 🔍 Dr. Peng Wang, PhD, will share strategies for optimizing ADCs, overcoming resistance, and combining them with immuno-oncology therapies. ➡️ REGISTER HERE: https://buff.ly/3A9LOzt #DrugDevelopment #PrecisionMedicine #DrugDiscovery #ClinicalResearch #Oncology #OncologyDrugs #TherapeuticAreas #AntibodyDrugConjugate #PreClinical #BasicResearch
To view or add a comment, sign in
-
DELFI Diagnostics published promising data in the journal Cancer Discovery, outlining the performance and potential of its blood-based #AI test to screen for #lungcancer. https://lnkd.in/de2aS-gv #artificialintelligence #biotechnology #clinicalresearch #DELFIDiagnostics #diagnostics #imaging #IVDs #medicalaffairs #oncology
Delfi's AI-based blood test shows promise in lung cancer study
To view or add a comment, sign in
-
Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. 🔎 At Parexel, our team of experts is leveraging diverse data streams and exciting advances in #AI and #machinelearning to fast-track cancer research and improve patient outcomes. We asked Angela Qu to describe how recent advances in multi-omics and computational analytics accelerate the discovery and validation of biomarkers in precision oncology. Read her responses at the link below! #Biomarkers #Oncology #PrecisionOncology #NovelInsights
Biomarker Development for Cancer | Parexel
share.parexel.social
To view or add a comment, sign in
-
Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. 🔎 At Parexel, our team of experts is leveraging diverse data streams and exciting advances in #AI and #machinelearning to fast-track cancer research and improve patient outcomes. We asked Angela Qu to describe how recent advances in multi-omics and computational analytics accelerate the discovery and validation of biomarkers in precision oncology. Read her responses at the link below! #Biomarkers #Oncology #PrecisionOncology #NovelInsights
Biomarker Development for Cancer | Parexel
share.parexel.social
To view or add a comment, sign in
-
Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. 🔎 At Parexel, our team of experts is leveraging diverse data streams and exciting advances in #AI and #machinelearning to fast-track cancer research and improve patient outcomes. We asked Angela Qu to describe how recent advances in multi-omics and computational analytics accelerate the discovery and validation of biomarkers in precision oncology. Read her responses at the link below! #Biomarkers #Oncology #PrecisionOncology #NovelInsights
Biomarker Development for Cancer | Parexel
share.parexel.social
To view or add a comment, sign in
-
🔬 Join Wren Laboratories for an upcoming webinar to explore the transformative potential of #liquidbiopsy and multigene mRNA expression assays in clinical trials. Abdel Halim, PharmD, MSc, PhD, DABCC will showcase the clinical validity of NETest® and PROSTest® assays for neuroendocrine tumors and prostate cancer, while also discussing their use in biomarker discovery, proof-of-concept (POC), and pharmacodynamics (PD) studies. 🔍 Learn more + register here: https://buff.ly/3XiuxvK #Biopsy #PrecisionMedicine #ClinicalResearch #Oncology #Biomarkers #CDx #Diagnostics #TherapeuticAreas #LaboratoryTechnology #LiquidBiopsyCancer
To view or add a comment, sign in
-
How can aligning cancer treatments with circadian rhythms improve outcomes? Ector et al. provide a high-throughput method [experimental and computational techniques] to optimize drug efficacy, paving the way for personalized medicine research. - - - Ector, C., Schmal, C., Didier, J. et al. Time-of-day effects of cancer drugs revealed by high-throughput deep phenotyping. Nat Commun 15, 7205 (2024). https://lnkd.in/dw_Nbcpn #Chronotherapy #CancerResearch #ComputationalBiomedicine - - -
To view or add a comment, sign in
2,422 followers